Healthcare company-building profile
JLABS @ NYC
Johnson & Johnson Innovation with New York State and the New York Genome Center
AcceleratorPharma acceleratorCorporateInactive or wound down
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- Pharma accelerator
- Organization
- Johnson & Johnson Innovation with New York State and the New York Genome Center
- Organization type
- Corporate
- Location
- New York, New York
- Company stage served
- Seed
- Cohort or participation model
- Rolling residency while operating; flexible-term lab and office leases
- Investment or funding offered
- Not publicly documented
- Published investment terms
- No equity or IP rights required as a condition of residency
- Equity or fee model
- No equity
- Clinical or hospital connection
- Not publicly documented
- Application status
- Inactive or wound down
- Founded
- 2018
Public description
About the program
JLABS @ NYC opened in partnership with New York State and the New York Genome Center to seed a life sciences incubator in Manhattan, offering wet-lab residency and access to J&J's scientific network. Johnson & Johnson closed the site after roughly eight years of operation as part of a broader consolidation of its JLABS footprint. It is included here as a wound-down corporate incubator site.
What the program publicly emphasizes
Focus areas and features
BiotechTherapeuticsGenomicsDiagnosticsBiotech and therapeuticsMedical devicesDigital health
- Category: Pharma accelerator
- Program structure: Rolling residency while operating; flexible-term lab and office leases
- Published terms: No equity or IP rights required as a condition of residency
Sources
External source links open in a new tab.